Washington Marriott Hotel, Washington, DC, USA
Apr 17 2012 8:00AM - Apr 18 2012 5:00PM
Type 2 Diabetes Mellitus Medications, QT, Benefit/Risk Assessment, Arrhythmias, Thrombosis, and Cardiotoxicity Join Industry Experts and Regulators to Improve Your Safety Analysis During Drug Development, Analyze and Mitigate Potential Risks, and Explore New Solutions and Approaches to Developing Safe and Effective Medications, including those to treat Type 2 Diabetes Mellitus. Participate in debate-style presentations and hear commentary and presentations from international industry, academic, and regulatory speakers to help you optimize your cardiovascular safety assessment and improve the development of medications to treat Type 2 Diabetes Mellitus and other diseases. FEATURES
• This meeting will offer plenary sessions and two tracks – one for Diabetes topics and one for CV safety topics
• Interact with FDA and other regulatory agency participants
• Scientific abstract presentation sessions
• Robust networking opportunites
Event Code:
12009
|
|